Format

Send to

Choose Destination
Oncotarget. 2016 Oct 4;7(40):64589-64604. doi: 10.18632/oncotarget.10905.

Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease.

Author information

1
Centre for Healthy Brain Ageing, School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia.
2
Department of Food Science and Nutrition, College of Agricultural and Marine Sciences, Sultan Qaboos University, Al Khoudh, Oman.
3
Ageing and Dementia Research Group, Sultan Qaboos University, Al Khoudh, Oman.
4
College of Medicine and Health Sciences, Sultan Qaboos University, Al Khoudh, Oman.
5
Department of Biochemistry and Biotechnology, Annamalai University, Tamil Nadu, India.
6
Illawarra Health and Medical Research Institute, University of Wollongong, NSW, Australia.
7
Neuropsychiatric Institute, The Prince of Wales Hospital, Sydney, Australia.
8
Neuroinflammation Group, MND and Neurodegenerative Diseases Research Centre, Macquarie University, NSW, Australia.

Abstract

Alzheimer's Disease (AD) is a progressive neurodegenerative disorder characterized by extracellular plaques containing abnormal Amyloid Beta (Aβ) aggregates, intracellular neurofibrillary tangles containing hyperphosphorylated tau protein, microglia-dominated neuroinflammation, and impairments in synaptic plasticity underlying cognitive deficits. Therapeutic strategies for the treatment of AD are currently limited. In this study, we investigated the effects of dietary supplementation of 4% pomegranate extract to a standard chow diet on neuroinflammation, and synaptic plasticity in APPsw/Tg2576 mice brain. Treatment with a custom mixed diet (pellets) containing 4% pomegranate for 15 months ameliorated the loss of synaptic structure proteins, namely PSD-95, Munc18-1, and SNAP25, synaptophysin, phosphorylation of Calcium/Calmodulin Dependent Protein Kinase IIα (p-CaMKIIα/ CaMKIIα), and phosphorylation of Cyclic AMP-Response Element Binding Protein (pCREB/CREB), inhibited neuroinflammatory activity, and enhanced autophagy, and activation of the phophoinositide-3-kinase-Akt-mammalian target of rapamycin signaling pathway. These neuroprotective effects were associated with reduced β-site cleavage of Amyloid Precursor Protein in APPsw/Tg2576 mice. Therefore, long-term supplementation with pomegranates can attenuate AD pathology by reducing inflammation, and altering APP-dependent processes.

KEYWORDS:

Gerotarget; amyloid beta protein; amyloid precursor protein; inflammation; pomegranates; synapse

PMID:
27486879
PMCID:
PMC5323101
DOI:
10.18632/oncotarget.10905
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center